Zoey Becker

2 days ago | fiercepharma.com | Zoey Becker

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. Mosquirix, or RTS.S., was brought to the world stage by GSK and PATH (formerly known as Program for Appropriate Technology in Health) in 2021 as the first malaria vaccine recommended by the World Health Organization (WHO).

3 days ago | fiercebiotech.com | Zoey Becker

While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, prevalent gastrointestinal side effects are leading the company to use a slower dosing schedule in its late-stage trials. Amgen presented the results of part 1 of its phase 2 MariTide study at the American Diabetes Association (ADA) 85 Scientific Sessions in Chicago on Monday, and the data were simultaneously published in the New England Journal of Medicine (NEJM).

4 days ago | fiercepharma.com | Zoey Becker

With a goal of boosting its life sciences economy into the top three of the global rankings by 2035, the U.K. government is laying out six specific areas of focus to bolster its growth in the industry. The interventions (PDF) come via the government’s new “Modern Industrial Strategy,” which prioritizes eight high-growth sectors and builds on a previous “Invest 2035” plan that was floated last year.

1 week ago | fiercepharma.com | Zoey Becker

As the saying goes, “If you don’t laugh, you’ll cry.” Biogen and ad agency 21Grams took that mantra to heart with their Gold Pharma Lions–winning social media campaign, “Friedreich’s Back,” for Friedreich’s ataxia (FA) treatment Skyclarys. At this year’s Cannes Lions International Festival of Creativity, they shared how they walked the fine line of humor in drug advertising.

1 week ago | fiercepharma.com | Ayla Ellison |Zoey Becker

Antibody-drug conjugates, or ADCs, are still holding on to their spot as one of the hottest areas in cancer care—and AbbVie, like many of its peers, has embraced the trend head-on. In this week’s episode of "The Top Line," Fierce Pharma’s Zoey Becker speaks with Daejin Abidoye, M.D., AbbVie’s vice president and therapeutic area head for solid tumor oncology.